about
Multidrug resistance in bacteriaExtended-spectrum beta-lactamases: a clinical updatePlasmid-determined AmpC-type beta-lactamases.Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatThree decades of beta-lactamase inhibitorsDetection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical centerbeta-Lactamases in laboratory and clinical resistanceA functional classification scheme for beta-lactamases and its correlation with molecular structureRotating antibiotics in the intensive care unit: feasible, apparently beneficial, but questions remain.Dio-Sensimedia: a novel culture medium for rapid detection of extended spectrum beta-lactamasesNosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalenceMechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolonesPenicillin-binding proteins and bacterial resistance to beta-lactamsThe catalytic mechanism of beta-lactamases: NMR titration of an active-site lysine residue of the TEM-1 enzymeTrends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.The growing burden of antimicrobial resistance.Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitorsAmino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase.New beta -lactamase inhibitory protein (BLIP-I) from Streptomyces exfoliatus SMF19 and its roles on the morphological differentiation.Comparison of five different methods for detection of SHV extended-spectrum beta-lactamases.Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel.Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea.Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom.Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniaeCeftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamasesPlasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strainsbeta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, MissouriCTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in LatviaA237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamasesAminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria.Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistanceSequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases.Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
P2860
Q22255652-6C93AE8F-EECF-4F5D-BD45-2554FC48D5F6Q24534999-4A39FE22-E323-4FDE-9480-BC8BFB8F8D8DQ24535748-DDD9D557-3AD0-46EB-A359-ED5E907DD25FQ24550671-EE20C602-B409-47D0-A992-8360F25F4BC9Q24646623-A523A330-7F84-476C-ADF5-8B4899BFFBFDQ24653870-5637662A-1E09-404A-AA34-C383EF9262C6Q24669605-9F809939-9327-4399-9879-302992A86301Q24677460-CC74CE5E-2B14-45B0-AED8-B59CBF9EEA84Q24798006-5F970EA6-B0E6-4CF6-BEB9-9288BD2679D8Q24805202-F161711C-B187-4446-817E-F9A7908052ACQ25257162-4A51A16F-6986-4FD0-B8C2-45CBBF45112BQ26828604-AC282BE7-FB28-4423-842F-9E925B7833E3Q28257231-EEEDC98C-9A73-4569-8DBD-E8477D8FD6ADQ28284215-325013F6-925F-43CA-B15E-830AB6A8076DQ30354148-5B81F87B-E903-49C8-9316-1FA0821E9ACCQ30371239-A4E8E382-910F-4462-9D7C-1095D47F1D9FQ30491327-FD827CC0-CBED-4C4C-94F2-2EC71DAFF952Q30731622-414195CA-1187-4C78-9FC9-A3CCB56A49ACQ30854268-5EE5ED7E-58E6-4383-92C9-BE37CCE880E1Q32100538-D7DD1892-1702-448C-827F-3CEFC9A85D0BQ33464072-5C32E6E9-648D-4816-BDB0-5D2295E333F6Q33666596-5491E379-2685-4552-A2D0-84226D16DDDCQ33667767-2BD2B3E6-9079-4826-82C2-479542EB287BQ33680541-4E5597EB-D031-4D24-A4FC-D1204323FDC6Q33690464-3BBAAF25-60EF-4758-BD4B-3A545354584AQ33690561-236519D2-933D-498A-B60D-8EA12A5A028BQ33690855-5B994EDE-EE15-4849-B709-F243F68BB4C4Q33691113-5FDDD729-A7E9-4F6F-A19D-E1EB33468E32Q33693251-4B2C0834-B7B6-4749-86DA-38D7F523F72EQ33693581-0D037DEB-D411-46F0-B278-B09A4BE3D0CDQ33694016-7B62169C-CD37-4381-B36A-727138142062Q33694083-FAEBBCB1-AF64-4575-B0A0-F08BC85EA639Q33694795-61063651-564F-42B1-9372-3DBF49154D81Q33695143-652EB173-76F4-4375-870A-2C9A8E3AC86EQ33746066-F7875D44-7152-431E-B594-0459469C610AQ33746844-CD3816F4-71D6-49EF-8D09-37F0CE635A14Q33747222-4307B900-5E41-40E3-BB7A-AAABE06FB789Q33747422-B6277B87-5C3B-4B3F-B150-E783F3DAC1D4Q33750810-4E25C30A-0C38-4391-9CF6-CB6AF0096B8CQ33752745-A1A66A42-CF57-4670-81C5-A1B500B09D19
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on September 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
More extended-spectrum beta-lactamases
@en
More extended-spectrum beta-lactamases.
@nl
type
label
More extended-spectrum beta-lactamases
@en
More extended-spectrum beta-lactamases.
@nl
prefLabel
More extended-spectrum beta-lactamases
@en
More extended-spectrum beta-lactamases.
@nl
P2860
P356
P1476
More extended-spectrum beta-lactamases
@en
P2093
Medeiros AA
P2860
P304
P356
10.1128/AAC.35.9.1697
P407
P577
1991-09-01T00:00:00Z